“It’s complicated” - talking about gout medicines in primary care consultations: a qualitative study

Abstract

BackgroundGout is the most common form of inflammatory arthritis. It is associated with substantial co-morbidity and often managed in primary care. A greater understanding of the communication process between patients and healthcare professionals provides one way of improving the management of this condition. This paper describes communication about gout medicines and treatment between patients and primary care health professionals during routine consultations.MethodsVideo-recordings of 31 individual healthcare consultations between patients and a range of primary care practitioners (general practitioners, practice nurses, podiatrists, dietitians) from an archived database were reviewed. Consultations that encompassed any discussion about gout medicines and treatment were included (n = 27) and were not solely restricted to those where gout was the presenting complaint. Themes were derived from an inductive qualitative analysis, from clinical and linguistic perspectives, based on the conversation between patients and practitioners about medicines and visual observation of these interactions.ResultsA number of factors were identified that had the potential to impact on the optimal management of gout in primary care. These included level of patient knowledge, patient attitudes to medicines, and the attributes of practitioner communication with patients. The latter related to the style of delivery and content of the information provided, and the ability of practitioners to make use of opportunities that arose to discuss these issues.ConclusionsPatients with gout communicate at varying levels of complexity with a diverse range of primary care healthcare professionals about the treatment of their condition. It is important that all practitioners engaging with gout patients in this setting are knowledgeable about the current management of gout, provide clear, consistent and accurate messages, remain aware that these messages may need repeating over time, and are supportive of patients’ medicine-taking preferences.

How Can We Improve Disease Education in People with Gout?

“…Social workers should be a part of this multi-disciplinary approach, as they are trained to assess and explore issues around coping with chronic illness and treatment, including the financial, social and cultural factors which can impact patients’ understanding, decisions, and adherence in a profound way. Effective communication between multiple providers around patient care is also essential to ensure that consistent messages are given to patients, and treatment plans are understood by all clinicians involved [ 31 ].…”

“…The literature supports the need for a patient-centered approach to education for rheumatic diseases, including gout, which addresses the unique psychoeducational needs of individual patients [ 31 – 33 ]. This review will discuss the available literature on disease-specific education in people with gout and suggest directions for future research.…”

Improving gout education from patients’ perspectives: a focus group study of Māori and Pākehā people with gout

“…5 The ability of health-care providers to communicate consistent, clear information repeatedly to gout patients is crucial to improve medication adherence. 6 Despite the development of clinical guidelines, 7-10 gout management remains suboptimal. [11][12][13] Patient education is crucial for optimal gout management.…”

Elevated UMOD methylation level in peripheral blood is associated with gout risk

“…In the current study, only the male samples were selected since gout was predominant in males (a male/female ratio of 4:1) 29 , 30 . As shown in Table 1 , a total of 11 clinical characteristics were collected from all the individuals.…”